Novo Nordisk’s diabetes tablet candidate makes Fierce Biotech’s list of 2025’s biggest clinical trial disappointments.
发布者:BY Maria Outze,转转请注明出处:https://robotalks.cn/top-clinical-trial-disappointments-of-2025-highlighted-by-industry-media/
Novo Nordisk’s diabetes tablet candidate makes Fierce Biotech’s list of 2025’s biggest clinical trial disappointments.
发布者:BY Maria Outze,转转请注明出处:https://robotalks.cn/top-clinical-trial-disappointments-of-2025-highlighted-by-industry-media/